Tumor Necrosis Factor α (TNFα) Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor Necrosis Factor α (TNFα) Inhibitor, covering 2025-02-18 to 2025-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis [Phase 4]